Singapore: Inovio Pharmaceuticals revealed that its SynCon DNA vaccine has demonstrated strong and durable antibody and ...
Singapore: China based manufacturer and supplier of refrigeration and cold chain equipments, AUCMA, has partnered with G...
Scientist, entrepreneur, administrator, adviser. Dr Chi-Huey Wong, the ninth president of Academia Sinica, has donned ma...
Singapore: A pneumococcal vaccine, Synflorix, by GlaxoSmithKline will be be introduced into the national immunization pr...
Singapore: A research team led by Academia Sinica President, Dr. Chi-Huey Wong, and associate research fellow, Dr Chung-...
Singapore: Bahrain's health ministry has almost doubled its annual order of flu vaccines following fears of MERS corona...
Pune: The phase III trial of RotaVac, India's first indigenously developed rotavirus vaccine, has been completed and the...
Singapore: Leading vaccine provider from Taiwan, Adimmune Corp has passed the third phase of clinical trials for H7N9 Av...
Singapore: The European Medicines Agency has issued a scientific opinion recommending that the benefits of the vaccine H...
Pune-based Serum Institute of India (SIIL), one of the largest providers of affordable quality vaccines in the world, ha...
Academia Sinica is an autonomous research institution in Taiwan that is doing pioneering work in the field of science an...
Singapore: The US FDA has approved Novartis' Menveo (Meningococcal Group A, C, W-135 and Y conjugate vaccine) for the p...
Singapore: GlaxoSmithKline (GSK) has received approval from the US FDA for Flulaval Quadrivalent (influenza virus vaccin...
Singapore: The US NIH announced that it is all set to launch an early-stage clinical trial of an experimental vaccine ag...
Singapore: China-based Simcere Pharmaceutical clocked $85.1 million revenue for the first quarter of 2013, representing ...
Singapore: Taiwan-based Adimmune has highlighted that it can begin supplying vaccines against the current strain of H7N9...
Singapore: The Vaccines Industry Association of New Zealand (VIANZ) has merged with the industry body Medicines New Zeal...
Singapore: US-based PaxVax, a specialty vaccine company, has confirmed positive efficacy results from 90-day challenge s...
